Key result
Tricuspid valve replacement was associated with higher risks of reintervention and heart failure rehospitalization compared to repair, with no difference in mortality.
Why the study?
Although tricuspid valve repair is recommended for tricuspid regurgitation, concern remains regarding its long-term durability compared with replacement.
Does tricuspid valve repair improve long-term outcomes compared to tricuspid valve replacement in patients undergoing tricuspid valve surgery?
Cohort (n=1,161)
Does tricuspid valve repair improve long-term outcomes compared to tricuspid valve replacement in patients undergoing tricuspid valve surgery?
Answers are grounded in this paper and cite their sources.
Tricuspid valve repair is associated with lower rates of reintervention and heart failure rehospitalization compared to replacement, supporting its use as the preferred surgical approach.
Background Tricuspid valve repair (TVr) is the recommended approach for managing tricuspid regurgitation; however, there is a concern about the long-term durability of the repair. Therefore, this study aimed to compare the long-term outcomes of TVr versus tricuspid valve replacement (TVR) in a matched cohort of patients. Methods This study included 1161 patients who underwent tricuspid valve (TV) surgery from 2009 to 2020. Patients were grouped according to the procedure into two groups: patients who underwent TVr ( n = 1020) and patients who underwent TVR (n = 159). The propensity score identified 135 matched pairs. Results Renal replacement therapy and bleeding were significantly higher in the TVR group compared to the TVr group both before and after matching. Thirty-day mortality occurred in 38 (3.79%) patients in TVr group versus 3 (1.89%) in the TVR group ( P ≤ 0.001) but was not significant after matching. After matching, TV reintervention (hazard ratio (HR): 21.44 (95% CI: 2.17–211.95); P = 0.009) and heart failure rehospitalization (HR: 1.89 (95% CI: 1.13–3.16); P = 0.015) were significantly higher in the TVR group. There was no difference in mortality in the matched cohort (HR: 1.63 (95% CI: 0.72–3.70); P = 0.25). Conclusions TVr was associated with lower renal impairment, reintervention, and heart failure rehospitalization than replacement. TVr remains the preferred approach whenever feasible.
No takes yet. Share an insight, caveat, or question.
Alghamdi et al. (2023) conducted a cohort in Tricuspid regurgitation (n=1,161). Tricuspid valve replacement (TVR) vs. Tricuspid valve repair (TVr) was evaluated on Mortality (HR 1.63, 95% CI 0.72-3.70, p=0.25). Tricuspid valve replacement was associated with higher risks of reintervention and heart failure rehospitalization compared to repair, with no difference in mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: